Celldex Therapeutics Inc (NASDAQ:CLDX)

30.10
Delayed Data
As of Apr 24
 +0.19 / +0.64%
Today’s Change
10.76
Today|||52-Week Range
32.82
+64.93%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues416.0K592.0K1.1M1.5M
 
 
 
 
 
Depreciation And Amortization832.0K836.0K857.0K877.0K
 
 
 
 
 
 
Operating ExpensesGross Income-416.0K-244.0K244.0K600.0K
 
 
 
 
 
General Expenses31.1M28.3M30.6M32.7M
 
 
 
 
 
Research And Development27.1M24.1M26.2M26.4M
 
 
 
 
 
Total Operating Expenses31.9M29.1M31.4M33.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-31.5M-28.5M-30.3M-32.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-29.9M-28.3M-28.1M-31.8M
 
 
 
 
 
Net Income-29.9M-28.3M-28.1M-31.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS89.3M89.4M89.4M89.6M
 
 
 
 
 
Shares To Calculate EPS Diluted89.3M89.4M89.4M89.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.33-$0.32-$0.31-$0.36
 
 
 
 
 
EPS Diluted-$0.33-$0.32-$0.31-$0.36
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account